Colloid Pattern of Salivary Mucinous Adenocarcinomas With Recurrent BRAF V600E Mutations

被引:2
|
作者
Zhang, Ye [1 ,2 ,3 ,4 ,5 ]
Zhou, Zheng [1 ,2 ,3 ,4 ,5 ]
Liu, Xiaoxiao [1 ,2 ,3 ,4 ,5 ]
Zhu, Lijing [1 ,2 ,3 ,4 ,5 ]
Cui, Yajuan [1 ,2 ,3 ,4 ,5 ]
Li, Tie-jun [1 ,2 ,3 ,4 ,5 ]
Zhou, Chuan-Xiang [1 ,2 ,3 ,4 ,5 ]
机构
[1] Peking Univ, Sch & Hosp Stomatol, Dept Oral Pathol, Beijing 100081, Peoples R China
[2] Natl Ctr Stomatol, Beijing, Peoples R China
[3] Natl Clin Res Ctr Oral Dis, Beijing, Peoples R China
[4] Natl Engn Res Ctr Oral Biomat & Digital Med Device, Beijing, Peoples R China
[5] Chinese Acad Med Sci 2019RU034, Res Unit Precis Pathol Diag Tumors Oral & Maxillof, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
salivary mucinous adenocarcinoma; colloid carcinoma; papillary carcinoma; AKT1 E17K mutation; BRAF V600E mutation; CARCINOMA;
D O I
10.1097/PAS.0000000000002164
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The relationship between various patterns of mucin-producing salivary adenocarcinomas, including invasive salivary adenocarcinomas with mucinous differentiation, such as colloid and papillary carcinomas, remains unclear. Herein, we aimed to describe the clinicopathologic characteristics, immunophenotypes, molecular underpinnings, and clinical behavior of salivary mucinous adenocarcinomas (MA) to clarify their classification. We described a broad series of colloid and papillary patterns of MAs, indicating that papillary pattern presented papillary cystic proliferation of mucinous columnar cells as salivary intraductal papillary mucinous neoplasms with recurrent AKT1 E17K mutations, whereas colloid adenocarcinomas containing large mucinous pools or lakes around the malignant epithelial nests or islands harbored BRAF V600E mutations with worse prognosis. Typical morphologic structures, CK7(+), CK20(-), CDX2(-), p63(-), p40(-), MAML2 fluorescence in situ hybridization (-), AR(-), TTF-1(-), S100(-), mammaglobin(-), or S100/mammaglobin(+) with ETV6 fluorescence in situ hybridization (-) immunophenotype, and recurrent AKT1 E17K or BRAF V600E mutations may be defined. To our knowledge, this small series represents the first genetic study on a typical colloid pattern of MA, and our study with the spectrum documentation for MA in clinicopathologic characteristics, histologic and immunophenotypes, molecular features, and clinical behavior will allow for a better understanding of these rare but distinctive tumors.
引用
收藏
页码:266 / 274
页数:9
相关论文
共 50 条
  • [32] Recurrent papillary glioneuronal tumor presenting as a ganglioglioma with the BRAF V600E mutation
    Momota, Hiroyuki
    Shimoyama, Yoshie
    NEUROPATHOLOGY, 2015, 35 (06) : 603 - 605
  • [33] Frequency of BRAF V600E mutations in 969 central nervous system neoplasms
    Behling, Felix
    Barrantes-Freer, Alonso
    Skardelly, Marco
    Nieser, Maike
    Christians, Arne
    Stockhammer, Florian
    Rohde, Veit
    Tatagiba, Marcos
    Hartmann, Christian
    Stadelmann, Christine
    Schittenhelm, Jens
    DIAGNOSTIC PATHOLOGY, 2016, 11
  • [34] Frequency of BRAF V600E mutations in 969 central nervous system neoplasms
    Felix Behling
    Alonso Barrantes-Freer
    Marco Skardelly
    Maike Nieser
    Arne Christians
    Florian Stockhammer
    Veit Rohde
    Marcos Tatagiba
    Christian Hartmann
    Christine Stadelmann
    Jens Schittenhelm
    Diagnostic Pathology, 11
  • [35] BRAF V600E mutations in benign and malignant peripheral nerve sheath tumors
    Serrano, C.
    Simonetti, S.
    Hernandez, J.
    Valverde, C.
    Carles, J.
    Bague, S.
    Orellana, R.
    Somoza, R.
    Ramon y Cajal, S.
    Romagosa, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] Enzymatic Enrichment of BRAF V600E Mutations: A Method to Improve Assay Sensitivity
    Ma, L.
    Maj, A.
    Baltadjieva, B.
    Mazur, L.
    Mihalov, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 748 - 748
  • [37] Papillary thyroid carcinomas with and without BRAF? V600E mutations are morphologically distinct
    Finkelstein, Alexander
    Levy, Gillian H.
    Hui, Pei
    Prasad, Avinash
    Virk, Renu
    Chhieng, David C.
    Carling, Tobias
    Roman, Sanziana A.
    Sosa, Julie A.
    Udelsman, Robert
    Theoharis, Constantine G.
    Prasad, Manju L.
    HISTOPATHOLOGY, 2012, 60 (07) : 1052 - 1059
  • [38] A Case of BRAF V600E Intrahepatic Cholangiocarcinoma
    Ahmed, Zarir
    Doane, Elizabeth
    Antao, Nirav
    Chhaparia, Anuj
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1314 - S1315
  • [39] RECURRENT GANGLIOGLIOMA WITH BRAF V600E MUTATION RESPONSE TO VEMURAFENIB: CASE REPORT
    Aguilera, Dolly
    Mazewski, Claire
    Janss, Anna
    Castellino, Robert Craig
    Schniederjan, Matthew
    Hayes, Laura
    Brahma, Barun
    MacDonald, Tobey
    NEURO-ONCOLOGY, 2014, 16 : 61 - 61
  • [40] BRAF V600E Immunohistochemistry in Colorectal Carcinoma
    Estrella, J. S.
    Tetzlaff, M. T.
    Kazen, C.
    Kopetz, S.
    Maru, D. M.
    Rashid, A.
    Hamilton, S. R.
    Broaddus, R. R.
    MODERN PATHOLOGY, 2014, 27 : 173A - 173A